Evidence map›Paper›PMID 36173379›Full record

ArticleThe Journal of cell biology2022

Cholesterol promotes clustering of PI(4,5)P2 driving unconventional secretion of FGF2.

Fabio Lolicato, Roberto Saleppico, Alessandra Griffo, Annalena Meyer, Federica Scollo, Bianca Pokrandt, Hans-Michael Müller, Helge Ewers, Hendrik Hähl, Jean-Baptiste Fleury and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Fabio Lolicato *Heidelberg University Biochemistry Center, Heidelberg, Germany.ORCID 0000-0001-7537-0549
Roberto Saleppico *Heidelberg University Biochemistry Center, Heidelberg, Germany.ORCID 0000-0003-0502-192X
Alessandra GriffoDepartment of Experimental Physics, Saarland University, Saarbrücken, Germany.ORCID 0000-0003-4588-1289
Annalena MeyerHeidelberg University Biochemistry Center, Heidelberg, Germany.
Federica ScolloDepartment of Biophysical Chemistry, J. Heyrovský Institute of Physical Chemistry, Czech Academy of Sciences, Prague, Czech Republic.ORCID 0000-0003-2238-006X
Bianca PokrandtHeidelberg University Biochemistry Center, Heidelberg, Germany.ORCID 0000-0003-2771-2035
Hans-Michael MüllerHeidelberg University Biochemistry Center, Heidelberg, Germany.ORCID 0000-0002-2384-7285
Helge EwersInstitute for Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.ORCID 0000-0003-3948-4332
Hendrik HählDepartment of Experimental Physics, Saarland University, Saarbrücken, Germany.ORCID 0000-0002-2708-0990
Jean-Baptiste FleuryDepartment of Experimental Physics, Saarland University, Saarbrücken, Germany.ORCID 0000-0003-1878-0108
Ralf SeemannDepartment of Experimental Physics, Saarland University, Saarbrücken, Germany.ORCID 0000-0002-4180-0819
Martin HofDepartment of Biophysical Chemistry, J. Heyrovský Institute of Physical Chemistry, Czech Academy of Sciences, Prague, Czech Republic.
Britta BrüggerHeidelberg University Biochemistry Center, Heidelberg, Germany.ORCID 0000-0002-3477-8270
Karin JacobsDepartment of Experimental Physics, Saarland University, Saarbrücken, Germany.ORCID 0000-0002-2963-2533
Ilpo VattulainenDepartment of Physics, University of Helsinki, Helsinki, Finland.ORCID 0000-0001-7408-3214
Walter NickelHeidelberg University Biochemistry Center, Heidelberg, Germany.ORCID 0000-0002-6496-8286
Heidelberg University · DESaarland University · DECzech Academy of Sciences, J. Heyrovský Institute of Physical Chemistry · CZUniversity of Helsinki · FIFreie Universität Berlin · DEMax Planck Institute for Medical Research · DEMax Planck School Matter to Life

Funding

Academy of FinlandBundesministerium für Bildung und ForschungCzech Science Foundation 19-26854XDeutsche Forschungsgemeinschaft SFB/TRR 83H2020 ProgrammeHelsinki Institute of Life ScienceHPC-EUROPA3 INFRAIA-2016-1-730897Human Frontier Science Program RGP0059/2019Max Planck SocietySigrid Juselius Foundation
6 · The paper itself

Abstract

FGF2 is a cell survival factor involved in tumor-induced angiogenesis that is secreted through an unconventional secretory pathway based upon direct protein translocation across the plasma membrane. Here, we demonstrate that both PI(4,5)P2-dependent FGF2 recruitment at the inner plasma membrane leaflet and FGF2 membrane translocation into the extracellular space are positively modulated by cholesterol in living cells. We further revealed cholesterol to enhance FGF2 binding to PI(4,5)P2-containing lipid bilayers. Based on extensive atomistic molecular dynamics (MD) simulations and membrane tension experiments, we proposed cholesterol to modulate FGF2 binding to PI(4,5)P2 by (i) increasing head group visibility of PI(4,5)P2 on the membrane surface, (ii) increasing avidity by cholesterol-induced clustering of PI(4,5)P2 molecules triggering FGF2 oligomerization, and (iii) increasing membrane tension facilitating the formation of lipidic membrane pores. Our findings have general implications for phosphoinositide-dependent protein recruitment to membranes and explain the highly selective targeting of FGF2 toward the plasma membrane, the subcellular site of FGF2 membrane translocation during unconventional secretion of FGF2.

Indexed as

CholesterolFibroblast Growth Factor 2Lipid BilayersPhosphatidylinositol 4,5-DiphosphateCell MembraneCholesterolFibroblast Growth Factor 2Lipid BilayersPhosphatidylinositol 4,5-Diphosphate

Identifiers

PMID36173379
PMCPMC9526255
OpenAlexW4297972673

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.